Preparative
Pharma firms hopeful for year ahead
Mar 16 2012
Pharma firms around the world are broadly hopeful about revenue growth over the next 12 months, according to a new study.
Nearly half – 47 per cent – of respondents to the study by iCD Research said they were "more optimistic" about growth.
Some 28 per cent said they were "neutral" and 23 per cent said they were less optimistic.
However, ongoing economic concerns have led to firms revising down their forecasts, with global economic growth projected to be 2.5 per cent in 2012 and 3.1 per cent in 2013.
This is down from estimates of 3.6 per cent. Market turmoil in Europe and lagging growth in emerging economies are fuelling the revised forecasts, iCD said.
But emerging markets – China, India and Brazil – are set to see positive growth rates this year, spearheaded by China, which will enjoy double digit growth on the back of a successful 2011.
According to separate research by Espicom, the UK pharma market is set to experience moderate growth over the coming years.
Posted by Fiona Griffiths
Events
Jun 01 2025 Baltimore, MD, USA
Jun 15 2025 Bruges, Belgium
Jul 14 2025 Kuala Lumpur, Malaylsia
Jul 15 2025 Brighton, UK
ACS National Meeting - Fall 2025
Aug 17 2025 Washington DC, USA & Virtual